Telemark Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$26M |
| 2 |
ServiceNow
NOW
|
+$12.3M |
| 3 |
F5
FFIV
|
+$11.6M |
| 4 |
CoStar Group
CSGP
|
+$11.4M |
| 5 |
Impinj
PI
|
+$10.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$29.7M |
| 2 |
NVIDIA
NVDA
|
+$29.5M |
| 3 |
Arm
ARM
|
+$21.3M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$18.2M |
| 5 |
Alcoa
AA
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.76% |
| 2 | Industrials | 21.54% |
| 3 | Healthcare | 8.03% |
| 4 | Energy | 7.59% |
| 5 | Materials | 6.05% |
Similar funds
Telemark Asset Management's Q3 2024 Portfolio in Review
As of Q3 2024, Telemark Asset Management held 72 positions worth $990M, down 14% from $1.15B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Telemark Asset Management withdrew a net $180M in Q3 2024, closing 16 positions and reducing 15 holdings. Its most notable exit was Moderna, an estimated $29.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 44% of assets, down from 46% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Telemark Asset Management opened a new position in Alnylam Pharmaceuticals worth $27.5M.
- Telemark Asset Management's largest Q3 2024 buy was Alnylam Pharmaceuticals: 100,000 shares worth $27.5M.
- Telemark Asset Management added most to ServiceNow in Q3 2024, an estimated $12.3M increase.
- Telemark Asset Management's biggest Q3 2024 reduction was NVIDIA, cutting an estimated $29.5M.
- Telemark Asset Management fully exited Moderna in Q3 2024, selling an estimated $29.7M.
- Telemark Asset Management's ten largest holdings make up 49% of its $990M portfolio in Q3 2024.
- Telemark Asset Management opened 14 new positions and closed 16 in Q3 2024.
- Telemark Asset Management's portfolio value fell 14% quarter-over-quarter to $990M.
Based on Telemark Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.